[go: up one dir, main page]

DE69822496D1 - Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen - Google Patents

Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen

Info

Publication number
DE69822496D1
DE69822496D1 DE69822496T DE69822496T DE69822496D1 DE 69822496 D1 DE69822496 D1 DE 69822496D1 DE 69822496 T DE69822496 T DE 69822496T DE 69822496 T DE69822496 T DE 69822496T DE 69822496 D1 DE69822496 D1 DE 69822496D1
Authority
DE
Germany
Prior art keywords
porphyrine
lyophilisate
insoluble
water
lipid complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69822496T
Other languages
English (en)
Other versions
DE69822496T2 (de
Inventor
Mathew Cherian
Prakash Apte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69822496D1 publication Critical patent/DE69822496D1/de
Publication of DE69822496T2 publication Critical patent/DE69822496T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69822496T 1997-01-28 1998-01-28 Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen Expired - Fee Related DE69822496T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78956697A 1997-01-28 1997-01-28
US789566 1997-01-28
PCT/US1998/000033 WO1998032463A2 (en) 1997-01-28 1998-01-28 Lyophilizate of lipid complex of water insoluble porphyrins

Publications (2)

Publication Number Publication Date
DE69822496D1 true DE69822496D1 (de) 2004-04-22
DE69822496T2 DE69822496T2 (de) 2005-03-03

Family

ID=25148009

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69822496T Expired - Fee Related DE69822496T2 (de) 1997-01-28 1998-01-28 Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen

Country Status (9)

Country Link
EP (1) EP1030686B1 (de)
JP (1) JP2001511128A (de)
AT (1) ATE261736T1 (de)
AU (1) AU6015298A (de)
DE (1) DE69822496T2 (de)
DK (1) DK1030686T3 (de)
ES (1) ES2218805T3 (de)
PT (1) PT1030686E (de)
WO (1) WO1998032463A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1731150A4 (de) * 2004-03-04 2010-06-16 Makoto Yuasa Niosom mit einem darin eingebetteten metall-porphyrin-komplex; verfahren zu seiner herstellung und damit zu verwendendes arzneimittel
JP4591820B2 (ja) * 2005-01-31 2010-12-01 株式会社ケムコ 化学発光試薬
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US8052996B2 (en) 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
PL2157967T3 (pl) 2007-04-23 2013-06-28 Intarcia Therapeutics Inc Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2015027176A1 (en) 2013-08-22 2015-02-26 Sony Corporation Water soluble fluorescent or colored dyes and methods for their use
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MX2017015504A (es) 2015-06-03 2018-05-15 Intarcia Therapeutics Inc Sistemas de colocacion y remoción de implante.
KR102773661B1 (ko) 2016-04-01 2025-02-27 소니그룹주식회사 초휘도 이량체성 또는 중합체성 염료
KR102526802B1 (ko) 2016-05-11 2023-05-02 소니그룹주식회사 초고명도 이량체성 또는 중합체성 염료
CA3024479A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US12018159B2 (en) 2016-07-29 2024-06-25 Sony Group Corporation Ultra bright dimeric or polymeric dyes and methods for preparation of the same
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
WO2019071208A1 (en) 2017-10-05 2019-04-11 Sony Corporation PROGRAMMABLE POLYMERIC MEDICAMENTS
WO2019071153A1 (en) * 2017-10-05 2019-04-11 Sony Corporation PROGRAMMABLE DENDRITIC MEDICINES
US11931419B2 (en) 2017-11-16 2024-03-19 Sony Group Corporation Programmable polymeric drugs
US12076407B2 (en) 2018-01-12 2024-09-03 Sony Group Corporation Polymers with rigid spacing groups comprising biologically active compounds
JP2021510698A (ja) 2018-01-12 2021-04-30 ソニー株式会社 生物学的に活性な化合物を含むホスホアルキルリボースポリマー
EP4137818A1 (de) 2018-03-19 2023-02-22 Sony Group Corporation Verwendung von zweiwertigen metallen zur verstärkung von fluoreszenten signalen
JP7580689B2 (ja) 2018-06-27 2024-11-12 ソニーグループ株式会社 デオキシリボースを含むリンカー基を有するポリマー色素
KR102718543B1 (ko) 2019-09-26 2024-10-18 소니그룹주식회사 링커 그룹을 갖는 중합체성 탠덤 염료

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer

Also Published As

Publication number Publication date
JP2001511128A (ja) 2001-08-07
WO1998032463A3 (en) 1998-10-22
DK1030686T3 (da) 2004-04-13
ATE261736T1 (de) 2004-04-15
WO1998032463A2 (en) 1998-07-30
AU6015298A (en) 1998-08-18
PT1030686E (pt) 2004-06-30
EP1030686A2 (de) 2000-08-30
ES2218805T3 (es) 2004-11-16
DE69822496T2 (de) 2005-03-03
EP1030686B1 (de) 2004-03-17

Similar Documents

Publication Publication Date Title
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
AU2709495A (en) Sphingosomes for enhanced drug delivery
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE259650T1 (de) Verfahren zur verringerung und zur erhaltung von verringerten blutspiegeln von lipiden mittels zubereitungen von ob-proteinen
ATE193418T1 (de) Dekontaminierung von plättchen mit 8- methoxypsoralen
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
HUP0001266A2 (hu) Nagyon kis oldhatóságú platinakomplexek lipidkomplexei és liposzómái
DK0539479T3 (da) Heterocykliske forbindelser
DE59005281D1 (de) Pharmazeutische präparate.
GR1000617B (el) Εφαρμοζόμενα μέσω του δέρματος φαρμακευτικά σκευάσματα με στερολίνες και/ή σπιροκεταλίνες.
DE69817379D1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
LV12149A (lv) 5-Aizvietoti mikofenolskabes 4-aminoatvasinajumi
DE59107762D1 (de) Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee